Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: November 1, 2010
Event: Announcement of a definitive Agreement and Plan of Merger with US Oncology Holdings, Inc.
Key Financial Metrics
This filing is a current report regarding a corporate transaction and does not contain periodic financial statements. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
- Merger Agreement: On November 1, 2010, McKesson Corporation and US Oncology Holdings, Inc. executed a Merger Agreement.
- Transaction Structure: The merger involves McKesson, its wholly owned subsidiary Utah Acquisition Corporation, US Oncology, and Utah Stockholders' Agent LLC.
- Disclosure: The Company held a conference call for investors and analysts on the date of the announcement to discuss the transaction.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release and a conference call transcript detailing the merger. No specific financial guidance or outlook for future periods is included in the text of this 8-K.
Risks and Contingencies: The filing includes a standard disclaimer regarding the Merger Agreement. It states that representations and warranties within the agreement were made for specific contractual purposes, may be subject to different materiality standards, and should not be relied upon as factual statements by persons other than the parties to the agreement.
Investor Verification Checklist
- Review the attached Agreement and Plan of Merger (Exhibit 99.3) for specific deal terms, consideration, and closing conditions.
- Read the Press Release (Exhibit 99.2) for strategic rationale and high-level transaction details.
- Consult the Conference Call Transcript (Exhibit 99.1) for management's detailed commentary on the acquisition.
- Verify the status of regulatory approvals and shareholder votes required to consummate the merger.